Opioid Labeling Changes Highlights AJPB Week in Review

Article

Top articles of the week from The American Journal of Pharmacy Benefits.

5. Polygenetic Test Predicts Early Heart Disease Risk

An investigational test demonstrated superiority in detecting familial hypercholesterolemia compared with traditional methods. Read more.

4. Diabetes Drug Reverses Alzheimer's Disease in Mice

Mice treated with a repurposed diabetes medication performed better on learning and memory tests. Read more.

3. Plastic Surgery May Hold the Key to Reducing Migraine Pain

Migraine pain may be caused by nerves trapped between muscles, bones, and fascia, which could be reduced by forehead restoration surgery. Read more.

2. Medicaid Expansion Increased Access to Prenatal Care

Expanded Medicaid reduced the number of uninsured pregnant mothers by 8%. Read more.

1. FDA Revises Opioid Labeling to Restrict Pediatric Use

Cough and cold medicines containing codeine and hydrocodone are no longer indicated for use in pediatric patients. Read more.

Related Videos
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Video 2 - "Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care"
Video 1 - "Identifying and Screening for Hepatic Encephalopathy Risk Factors"
© 2024 MJH Life Sciences

All rights reserved.